Having observed an upregulation of CD25 and, to a lesser degree, CD122 on tumor-infiltrating CD8+ T cells following a single dose of 20 Gy, we decided to combine 1 × 20 Gy with CD25-biased and CD122-biased IL-2cx (Figure 2A). The gene discussed is CD8A; the disease is neoplasm.